Search Results - "Bulgheroni, Elisabetta"

Refine Results
  1. 1

    Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors by Busnelli, Marta, Bulgheroni, Elisabetta, Manning, Maurice, Kleinau, Gunnar, Chini, Bice

    “…The neuropeptides oxytocin (OT) and vasopressin (AVP) have been shown to play a central role in social behaviors; as a consequence, they have been recognized…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells by Harari, Sergio, MD, Elia, Davide, MD, Torre, Olga, MD, Bulgheroni, Elisabetta, MSc, Provasi, Elena, PhD, Moss, Joel, MD, PhD, FCCP

    Published in Chest (01-08-2016)
    “…A young woman received a diagnosis of abdominal, sporadic lymphangioleiomyomatosis (LAM) and multiple abdominal lymphangioleiomyomas and was referred for…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Dual modulation of inward rectifier potassium currents in olfactory neuronal cells by promiscuous G protein coupling of the oxytocin receptor by Gravati, Marta, Busnelli, Marta, Bulgheroni, Elisabetta, Reversi, Alessandra, Spaiardi, Paolo, Parenti, Marco, Toselli, Mauro, Chini, Bice

    Published in Journal of neurochemistry (01-09-2010)
    “…J. Neurochem. (2010) 114, 1424-1435. Oxytocin receptor is a seven transmembrane receptor widely expressed in the CNS that triggers Gi or Gq protein-mediated…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene by Elia, Davide, Torre, Olga, Vasco, Chiara, Geginat, Jens, Abrignani, Sergio, Bulgheroni, Elisabetta, Carelli, Elena, Cassandro, Roberto, Pacheco-Rodriguez, Gustavo, Steagall, Wendy K., Moss, Joel, Harari, Sergio

    Published in Chest (01-08-2022)
    “…Lymphangioleiomyomatosis (LAM) and pulmonary Langerhans cell histiocytosis (PLCH) are cystic lung diseases in which a neoplastic cell is thought to be…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Combination of CCR5 and CXCR4 Inhibitors in Therapy of Human Immunodeficiency Virus Type 1 Infection: In Vitro Studies of Mixed Virus Infections by Rusconi, S, La Seta Catamancio, S, Citterio, P, Bulgheroni, E, Croce, F, Herrmann, S H, Offord, R E, Galli, M, Hirsch, M S

    Published in Journal of Virology (01-10-2000)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  11. 11

    Intracellular Modulation, Extracellular Disposal and Serum Increase of MiR-150 Mark Lymphocyte Activation: e75348 by Candia, Paola de, Torri, Anna, Gorletta, Tatiana, Fedeli, Maya, Bulgheroni, Elisabetta, Cheroni, Cristina, Marabita, Francesco, Crosti, Mariacristina, Moro, Monica, Pariani, Elena

    Published in PloS one (01-09-2013)
    “…Activated lymphocytes release nano-sized vesicles (exosomes) containing microRNAs that can be monitored in the bloodstream. We asked whether elicitation of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Analysis of the env V3 sequences obtained from patients with HIV type 1 infection treated with the immune modulant agent tucaresol by Bulgheroni, Elisabetta, Bandera, Alessandra, Galli, Massimo, Gori, Andrea, Rusconi, Stefano

    Published in AIDS research and human retroviruses (01-09-2005)
    “…Tucaresol, a Schiff base-forming compound that is shown to enhance cytotoxic T cell responses and the production of type 1 cytokines, represents a potentially…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Efficacy and tolerability of multiple drug therapy in HIV-infected children by Viganò, Alessandra, Schneider, Laura, Giacomet, Vania, Bianchi, Roberta, Cicero, Mirko Lo, Soster, Francesca, Bulgheroni, Elisabetta, Rusconi, Stefano

    Published in The Journal of infection (01-06-2005)
    “…To characterize the efficacy and tolerability of multiple drug therapy (MDT) among heavily pre-treated HIV-infected children. An observational study of seven…”
    Get full text
    Journal Article
  16. 16

    Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility by Bulgheroni, Elisabetta, Croce, Francesco, Citterio, Paola, Viganò, Ottavia, Visonà, Raffaella, Sala, Eugenio, Galli, Massimo, Rusconi, Stefano

    Published in Journal of clinical virology (2004)
    “…Introduction: Multiple amino acid changes in the reverse transcriptase (RT) enzyme of the human immunodeficiency virus 1 (HIV-1) confer simultaneous resistance…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Virological response in multidrug-experienced hiv-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine by RUSCONI, Stefano, LA SETA CATAMANCIO, Simona, CITTERIO, Paola, BULGHERONI, Elisabetta, KURTAGIC, Semir, GALAZZI, Morena, CROCE, Francesco, MORONI, Mauro, GALLI, Massimo

    Published in Antiviral therapy (01-03-2001)
    “…The aim of this study (the RESCUE trial) was to verify the effect of a shift from a lamivudine-containing to a didanosine-containing regimen on viral…”
    Get full text
    Conference Proceeding Journal Article
  19. 19

    In Vitro Inhibition of HIV-1 by Met-Sdf-1β Alone or in Combination with Antiretroviral Drugs by Rusconi, Stefano, Merrill, Debra P, La Seta Catamancio, Simona, Citterio, Paola, Bulgheroni, Elisabetta, Croce, Francesco, Chou, Ting-Chao, Yang, Otto O, Herrmann, Steven H, Galli, Massimo, Hirsch, Martin S

    Published in Antiviral therapy (01-09-2000)
    “…Compounds that can block the CXCR4 chemokine receptor are a promising new class of antiretroviral agents. In these experiments we studied the effect of a…”
    Get full text
    Journal Article
  20. 20

    Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure by Rusconi, S, De Pasquale, M P, Milazzo, L, Kurtagic, S, Bulgheroni, E, Citterio, P, Galazzi, M, La Seta Catamancio, S, Galli, M

    Published in Antiviral therapy (01-01-1998)
    “…We examined the in vitro phenotypic and genotypic profiles of an extensively passaged human immunodeficiency virus type 1 clinical isolate which has been…”
    Get more information
    Journal Article